INTRODUCTION
The discovery of a patient with genetically determined severe deficiency of C3 (1) and repeated infections provided the opportunity to investigate the genetic mechanism of the deficiency state and to examine the role of C3 in a variety of complement-dependent reactions. Her serum was grossly deficient in hemolytic complement and in opsonization for endotoxin particles. Furthermore, there was no cleavage of properdin factor B when her serum was incubated with zymosan. All of these abnormalities in vitro were corrected by the addition of purified C3 to her serum. There was no increase in peripheral blood polymorphonuclear leukocytes during the patient's episodes of severe systemic bacterial infection.
The nature of the inherited deficiency was suspected to be similar to that observed earlier only in heterozygotes (2) , in whom it could be shown that a blank C3 gene (C3-) was inherited as an allele of the common structural genes for C3, C38, and C3' (3). It was not possible at the time of the initial report of the present patient to demonstrate inheritance of a blank C3 gene in studies of the patient's immediate family; although her mother, father, and several siblings had half-normal levels of C3, in each instance it was C3 S.
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The present report is concerned with further studies of this patient. Blood samples from over 100 of her relatives were analyzed to define the mode of inheritance of the deficiency state. The role of C3 in immune adherence, in the generation of vascular permeability induced by Cls, in humoral antibody production, in cobra venom factor (CoF)1 induced passive hemolysis of guinea pig erythrocytes, and in leukocyte mobilization was explored. The metabolism of C3 in homozygous C3 deficiency was investigated, as well as the behavior of red cells from a patient with paroxysmal nocturnal hemoglobinuria (PNH) in the C3-deficient subject's circulation. METHODS Genetic typing of C3. C3 typing was performed in prolonged agarose gel electrophoresis as previously described (3) .
Quantitation of complement proteins. Functional hemolytic titrations of complement components were carried out by standard methods (4), as was the determination of total hemolytic complement (5) . Immunochemical estimations of complement protein concentration in serum were carried out by electroimmunoassay (6) .
Protein purification procedures. C3 was prepared by the method of Nilsson and Mfiller-Eberhard (7) and labeled with 'I by the iodine monochloride technique (8) of McFarlane. C1s was prepared by the method of Haines and Lepow (9) . The starting plasma, the purified proteins, or both, were tested for Hb.Ag by radioimmunoassay and were found to be negative. Radiolabeled C3 and PNH erythrocyte studies. The metabolism of 'I-labeled C3 was studied in the patient and a healthy normal subject as described previously (10) . The data were analyzed by the Matthews method (11) . The conversion of 'I-labeled C3 in the patient's serum in vitro was assessed by agarose gel electrophoresis and radioautography as described previously (12) .
Blood was obtained in acid citrate dextrose from a patient with PNH who had blood group B (as did the patient and the normal control). This blood was determined to be free of Hb.Ag by radioimmunoassay. The erythrocytes were labeled with 'Cr and the blood was stored for 4 days in cracked ice. 2 h before use, the erythrocytes were washed twice at 4VC in sterile physiologic saline containing 1% human serum albumin. 20 ml of washed 'Cr-labeled erythrocytes was injected intravenously into the patient and the normal control. The survival of these cells was determined by standard methods (13) . When the patient's serum was acidified to pH 6.6-6.8 and incubated for 30 min at 370C with erythrocytes from the patient with PNH in a Ham test (14) , no lysis of these cells was observed, whereas lysis was obtained when the PNH cells were incubated with acidified normal AB serum or with the patient's serum to which purified C3 had been added.
Immune adherence. Immune adherence was tested using serial dilutions of patient and normal serum in a standard method (15) .
Intradermal injection of Cls. Purified Cis (9) was injected intradermally on the forearm of the patient and two normal subjects who had received one ampoule of Evans blue dye a few minutes earlier. The average diameter of 1Abbreviations used in this paper: CoF, cobra venom factor; PNH, paroxysmal nocturnal hemoglobinuria.
bluing, the time of maximal bluing, and the extent of swelling were evaluated. The patient gave skin reactions identical to those of a normal control subject on the intradermal injection of 0.1 ml of 10 M histamine in saline and of 15 #g of morphine sulfate (a potent inducer of mast cell degranulation) in 0.1 ml saline.
Leukocytosis in response to endotoxin. An injection of 0.5 ml of typhoid vaccine was given intramuscularly and white cell counts and differential cell counts were performed at intervals for 6 h.
Antibody production. The patient's anti-blood group A agglutinating titer was determined by serial dilution. Her antibody response to diphtheria toxoid was evaluated by Dr. J. H. Mason of the serum-vaccine department of the South African Institute for Medical Research, Johannesburg, using a standard hemagglutination assay. The patient also received 50 jsg of the polyribose phosphate antigen of Haemophilus influenzae (16) and her antibody response was measured by a radioligand binding assay (16) . half-blackened symbols and the proposita, who is homozygous, is shown as a fully-blackened circle and indicated by an arrow. C3 types are given adjacent to the symbols for each individual. Diamonds refer to untested siblings and their number is given within the symbols. The halfstippled square indicates that the individual II-3 is untested, but he could be presumed to be heterozygous deficient (F-) from the C3 types of his children and siblings. Symbols enclosing dots refer to untested individuals whose types could not be presumed. Interaction of C3-deficient serum with CoF. The anticomplementary protein in the venom of the Indian hooded cobra (Naja naja) was isolated by Sephadex G-200 gel filtration (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) and preparative electrophoresis (17) . The purified material produced a single band in agarose gel electrophoresis. This material was incubated with serum at a final concentration of 20 ,ug/ml for 60 min at 370C. In some experiments, C3 and C5 destruction were measured by hemolytic titration (4) and in other experiments, guinea pig erythrocytes were added to the reaction mixture to measure passive lysis (18) . In the passive lysis experiments, all sera were absorbed three times for 15 min each at 0'C with 2.5 X 10' guinea pig erythrocytes/ml of serum to remove possible heterophile antibodies.
Lymphocyte receptors for C3. The patient's peripheral blood lymphocytes were tested for C3 receptors by a standard method (19) . By this technique, the normal percentage of B lymphocytes is 17-25%. RESULTS
Family studies. The family tree of the patient with C3 deficiency is shown in Fig. 1 Functional estimations of the nine components of complement in the proposita and her immediate family are given in Table I . It is evident that complement component levels except for C3 were normal in all family members. Hemolytic complement was slightly low in heterozygotes for C3 deficiency and undetectable in the proposita.
Metabolic studies with 'I-labeled C3. The results of the studies of the metabolism of radiolabeled C3 in the patient homozygous for C3 deficiency and a normal control subject are given in Table II . Although these studies demonstrate, as expected, that the patient's defect is accompanied by marked, if not complete, hyposynthesis, there was also an increased fractional cata- Fig. 2 . The conversion rate of 'I-labeled C3 in the C3-deficient patient's serum after 1 h of incubation at 370C was greater than that observed in normal serum, as shown in Fig. 3 . This modestly accelerated conversion was less than that observed in serum from a patient (12) with partial lipodystrophy and nephritic factor (C3ase). Furthermore, the conversion of C3 in the C3-deficient patient's serum was not accelerated by admixture with normal human serum (Fig. 3) or purified C3 to normal serum concentration (not shown), as occurred in the serum with nephritic factor.
Antibody response. The patient, who has blood group B, had an anti-A agglutinating titer of 1: 128 at room temperature. Before injection of 1 ml of diphtheriatetanus toxoid, the patient's serum contained 0.1-0.2 U/ml of antitoxin to diphtheria toxoid, unchanged 2 days after injection. By 8 days, however, her antitoxin level rose to 7.0 U/ml, constituting a normal anamnestic response. 2 wk after the injection of 50 ,*g of polyribose phosphate antigen from H. influenzae, the patient's serum contained approximately 30 ng antibody/ml, constituting a normal response.
In vivo survival of "Cr-labeled PNH red cells. The survival of radiolabeled erythrocytes from a patient with PNH was shortened in both the C3-deficient and normal subjects with no significant difference between the disap-IOD. The conversion in vitro of 'I-labeled C3 in the homozygous C3-deficient patient's serum. Labeled C3 was added to serum or serum mixtures and incubated for 1 h at 370C. Samples were then chilled and subjected to electrophoresis in agarose gel at pH 8.6 in barbital buffer (r/2 = 0.05) for approximately 45 min. After protein fixation, washing, and drying, radioautographs were made on Kodak No-screen X-ray film (Eastman Kodak Co., Rochester, N. Y.). Samples were (a) patient's serum, (b) a mixture of equal parts of patient's serum and normal serum, (c) serum from a patient with partial lipodystrophy and nephritic factor, (d) the strum with nephritic factor mixed with an equal volume of normal human serum, (e) normal serum, and (f) buffer alone. All the patterns shown are from the same electrophoresis plate.
pearance curves. The to in the normal subject was 17 days, whereas in the C3-deficient patient it was 16 days.
Immune adherence. Immune adherence was about one third reduced in C3-deficient serum compared with normal controls. The titer in C3 deficient serum was 1/800 compared with a normal control of 1/1,200.
Skin reaction to Cis. The results of the intradermal injection of Cis in the C3-deficient and normal subjects are given in Table III . No reaction was observed in the C3-deficient patient's skin on the injection of an amount of Cls that produced marked bluing in the normal subjects' skin.
Leukocyte response to typhoid vaccine. A normal leukocytosis occurred in the C3-deficient patient after the intramuscular injection of typhoid vaccine. The patient's white blood cells rose from 7,600/mm' before injection to 12,700 by 6 h after injection, with neutro- phils rising from 3,600 to 10,500 in the same period. The normal control subject's white blood cells rose from 6,600 to 9,300 and his neutrophils from 4,300 to 6,100/ mm' under the same conditions. CoF-induced passive hemolysis. When the C3-deficient patient's serum was incubated with purified CoF in the absence and presence of guinea pig erythrocytes, normal C5 destruction (Table IV) and normal lysis of guinea pig erythrocytes occurred (Table V) . That this lysis was complement-mediated is seen from the lack of lysis when this experiment was performed with C3b inactivator-deficient or C5-deficient human serum. These observations indicate that CoF-induced passive hemolysis requires C5 and a protein or proteins of the alternative pathway other than C3 but not C3 itself.
The patient had a normal number of circulating B lymphocytes as defined by the presence of C3 receptors. Of her lymphocytes, 18% had such receptors. DISCUSSION The inheritance pattern of C3 deficiency in the present family is identical to that observed earlier in a family with heterozygotes only (2) in which affected persons had inherited a gene, CS-, that produced no detectable product but was allelic to the structural C3 genes. In the present family, of 29 offspring of known or presumed heterozygotes, 16 were heterozygous deficient. Thus, C3-is inherited as an autosomal codominant trait, and the proposita is homozygous for this trait. This is consistent with the autosomal recessive mode of inheritance of marked C3 deficiency.
Since a heterozygote for C3 deficiency by chance married a first-degree relative of the proposita, it appears that C3-has a rather high frequency among Afrikaners in South Africa. This impression is strengthened by the establishment of the diagnosis of hereditary C3 deficiency in an Afrikaner child in Durban, South Africa.' That child died recently at the age of 7 and had a history of recurrent infections.
The metabolic studies with 'I-labeled C3 confirm that the C3-deficient subject fails to synthesize significant amounts of C3. The finding of an elevated frac-'Grayce, J., and G. Vos. Personal communication. (14) and that this lysis requires an intact alternative pathway (20) (21) (22) (23) . The failure, therefore, of the patient's serum to produce lysis of PNH erythrocytes is no surprise.
The shortened survival of erythrocytes from a patient with PNH in the C3-deficient subject's circulation may have one or both of two explanations. The cells may already have been damaged by complement through the C3 stage in the donor's circulation. Alternatively, complement may play no part in the shortened survival of random PNH red cells, since the bulk of complementsensitive cells are destroyed shortly after their emergence from the marrow (24) .
The lack of a vasopermeability response to the intradermal injection of Cis in the C3-deficient person's skin is puzzling. It is known that patients with very low levels of C3 (around 3% of the normal level) give a normal response, whereas C2-deficient subjects (25) give no response and C4-deficient guinea pigs have minimal swelling (26) . Nevertheless, the complete absence of a vasopermeability response to the intradermal injection of Cis in the C3-deficient patient strongly suggests a requirement for C3 or a protein in the alternative pathway for the elaboration of this response. It is unlikely but not impossible that the normal response to Cis is the result of generation of C3a, since it cannot be blocked by antihistaminics (26) , which effectively block the vasopermeability action of purified C3a (27) . It is conceivable that the patient has end-organ unresponsiveness to whatever is responsible for the reaction to Cls. This possible unresponsiveness must be prolonged if not continuous, because the patient has been tested on three separate occasions, two of which were 2 yr apart. Studies are in progress to define this problem further.
Since the early work on the anticomplementary effect of cobra venom on serum, attention has been focused on the serum-mediated attack on C3 (28-31). Jensen, however, provided convincing evidence that CoF attacked purified C5 after interaction with a serum protein free of C3 (32) . The passive lysis of unsensitized guinea pig erythrocytes by serum incubated with CoF (18) has been assumed to proceed via C3 activation and cleavage (18, 33 (1) .
In the initial report of the C3-deficient patient, the failure of infection with pyogenic organisms to induce a leukocytosis was noted (1), confirming Rother's observation in vitro that C3 is required for the mobilization of leukocytes from the rabbit femur (36) . The finding in the present studies that a normal leukocytosis developed in the patient in response to the injection of endotoxin in the form of typhoid vaccine suggests that there are several normal mechanisms whereby bacterial infection results in leukocytosis. Apparently the leukocytosis of infection with some pyogenic organisms is C3-dependent but that induced by endotoxin administration is not.
Although small differences in the thymus-dependent antibody response to sheep red blood cells were shown to occur in C3-depleted mice (37) 
